FLUZONE QUADRIVALENT (Sanofi Pasteur Inc.)


Welcome to the PulseAid listing for the FLUZONE QUADRIVALENT drug offered from Sanofi Pasteur Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: Sanofi Pasteur Inc.
NON-PROPRIETARY NAME: INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUK
SUBSTANCE NAME: INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUK
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30


FLUZONE QUADRIVALENT VACCINE Details:

Item DescriptionFLUZONE QUADRIVALENT from Sanofi Pasteur Inc.
LABELER NAME: Sanofi Pasteur Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30
PRODUCT ID: 49281-417_25e00f2b-d034-4059-ac64-82cb489857a5
PRODUCT NDC: 49281-417
APPLICATION NUMBER: BLA103914

Other INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUK Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanofi Pasteur Inc.FLUZONE QUADRIVALENT